Under the collaboration, the parties will evaluate engraftment and function of StemCells’s HuCNS-SC cells in the same rat model preparatory to planned clinical trials. The research, which is expected to be concluded by the end of 2008, will be conducted at OHSU.
Stephen Huhn, vice president and head of the CNS Program of StemCells, said: “This collaboration advances our mission to develop novel treatments for diseases of all three elements of the central nervous system – the brain, the spinal cord and the eye.”